The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2020 | A shifting paradigm: lung cancer

Name: A shifting paradigm: lung cancer
Uploaded: 2020-01-30T00:00:00Z
Duration: 1 min 30 s
Description: Stephen Liu, MD, MedStar Georgetown University Hospital, Washington, DC, outlines the research in the lung cancer field he is most excited about. Dr Liu outlines the utilization and value of immunotherapy in this setting. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Stephen Liu • 30 Jan 2020

BTOG 2020

Lung Cancer

Stephen Liu, MD, MedStar Georgetown University Hospital, Washington, DC, outlines the research in the lung cancer field he is most excited about. Dr Liu outlines the utilization and value of immunotherapy in this setting. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.